###begin article-title 0
Upstream ORF affects MYCN translation depending on exon 1b alternative splicing
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 68 74 68 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN) </italic>
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 109 110 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 103 110 103 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b</italic></sup>
The MYCN gene is transcribed into two major mRNAs: one full-length (MYCN) and one exon 1b-spliced (MYCNDelta1b) mRNA. But nothing is known about their respective ability to translate the MYCN protein.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 304 309 304 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 398 402 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 408 410 404 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 402 410 402 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 443 449 <span type="species:ncbi:9986">rabbit</span>
Plasmids were prepared to enable translation from the upstream (uORF) and major ORF of the two MYCN transcripts. Translation was studied after transfection in neuroblastoma SH-EP cell line. Impact of the upstream AUG on translation was evaluated after directed mutagenesis. Functional study with the two MYCN mRNAs was conducted by a cell viability assay. Existence of a new protein encoded by the MYCNDelta1b uORF was explored by designing a rabbit polyclonal antibody against a specific epitope of this protein.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 75 77 71 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 69 77 69 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 170 175 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 188 192 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 198 200 190 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 192 200 188 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 279 283 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 289 291 277 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 283 291 275 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 425 430 413 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 465 470 453 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 563 567 551 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 573 575 557 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 567 575 555 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
Both are translated, but higher levels of protein were seen with MYCNDelta1b mRNA. An upstream ORF was shown to have positive cis-regulatory activity on translation from MYCN but not from MYCNDelta1b mRNA. In transfected SH-EP neuroblastoma cells, high MYCN dosage obtained with MYCNDelta1b mRNA translation induces an antiapoptotic effect after serum deprivation that was not observed with low MYCN expression obtained with MYCN mRNA. Here, we showed that MYCNOT: MYCN Overlap Transcript, a new protein of unknown function is translated from the upstream AUG of MYCNDelta1b mRNA.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
Existence of upstream ORF in MYCN transcripts leads to a new level of MYCN regulation. The resulting MYCN dosage has a weak but significant anti-apoptotic activity after intrinsic apoptosis induction.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 35 36 35 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 259 264 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 340 344 340 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 350 352 346 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 344 352 344 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 358 359 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 360 361 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 404 408 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 414 415 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 408 418 404 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b</italic>,2 </sup>
###xml 424 425 416 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 433 438 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 442 446 434 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 452 454 440 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 446 454 438 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 636 640 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 646 648 630 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 640 648 628 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 692 693 676 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 734 739 718 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 741 745 725 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 751 752 731 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 745 755 729 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b</italic>,2 </sup>
###xml 847 848 823 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
The MYCN gene, located in 2p23-24 [1] has been demonstrated to be composed of three exons (Fig. 1): exon 1a/b, exon 2 and exon 3, and the coding sequence for MYCN has been mapped to exons 2 and 3 [2]. Several transcripts have been described; one full length: MYCN mRNA and two alternatively spliced mRNAs; one containing exons 1a, 2 and 3: MYCNDelta1b mRNA [2,3] and the other containing exons 1a and 3: MYCNDelta1b,2 mRNA [4]. Only MYCN and MYCNDelta1b transcripts might translate the MYCN protein. It was previously hypothesized but neither proven nor explored that an upstream AUG (uAUG) located in +1894 (according to GenBank: ) of MYCNDelta1b mRNA might translate a protein (GenBank: ) [5]. Moreover, as proposed by van Bokhoven et al, MYCNDelta1b,2 mRNA could be able to initiate translation of a new protein (DeltaMYCN) from the same uAUG [4].
###end p 10
###begin p 11
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 0 38 0 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The <italic>MYCN </italic>oncogene and encoded proteins</bold>
###xml 40 43 40 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a) </bold>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 93 96 93 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b) </bold>
###xml 150 154 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 156 159 156 159 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c) </bold>
###xml 238 239 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 320 326 <span type="species:ncbi:9986">rabbit</span>
The MYCN oncogene and encoded proteins. a) Annotated sequence of MYCN according to Genbank . b) Alternative splicing and putative proteins encoded by MYCN. c) MYCNOT sequence. Bold aminoacids: shared homology with the putative DeltaMYCN [4]. Underlined aminoacids: selected epitope for polyclonal antibody production in rabbit.
###end p 11
###begin p 12
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
The existence of upstream open reading frames (uORFs) has been described in detail for many genes, and these uORFs could represent as much as half of the whole transcriptome [6,7]. Most studies have shown a negative cis-regulatory function of the major ORF [6-8].
###end p 12
###begin p 13
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 621 623 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 300 305 <span type="species:ncbi:10090">mouse</span>
###xml 628 633 <span type="species:ncbi:10090">mouse</span>
###xml 665 670 <span type="species:ncbi:9031">chick</span>
MYCN, a basic helix-loop-helix transcription factor that belongs to the MYC family, was initially identified as a gene amplified in neuroblastoma, the most frequent paediatric extra-cranial solid tumour [9]. Numerous experiments have demonstrated its importance during ontogenesis. In the developing mouse embryo, MYCN is required for normal organogenesis of the heart, neural tube, spinal ganglia, visceral arches, liver, stomach, limb buds and eyes [10]. More precisely, MYCN is essential to maintain a population of undifferentiated and proliferating progenitor cells in the brain [11] and the distal lung epithelium [12] of mouse embryos. MYCN is also able, in chick embryos, to initiate the ventral migration of cells from the neural crest to the sympathetic ganglia and to induce their differentiation into neurons [13].
###end p 13
###begin p 14
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 341 362 341 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tyrosine Hydroxylase </italic>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 129 132 <span type="species:ncbi:10116">rat</span>
###xml 241 256 <span type="species:ncbi:10090">transgenic mice</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
The overexpression of MYCN in the presence of deregulated H-ras has been shown to contribute to the neoplastic transformation of rat embryo cells, suggesting an oncogenic role of MYCN [14]. This oncogenic role was later confirmed using MYCN-transgenic mice: targeted expression of MYCN to neural crest-derived cells under the control of the Tyrosine Hydroxylase promoter leads to the development of neuroblastoma-like tumours in all homozygous mice [15].
###end p 14
###begin p 15
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 440 445 440 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
The amplification and overexpression of MYCN primarily found in 25% of neuroblastomas are associated with advanced tumour stage, tumour progression and poor outcome [16]. MYCN can also be overexpressed in other tumours including medulloblastoma, retinoblastoma, small cell lung cancer, glioblastoma and other embryonal tumours [17] suggesting the implication of MYCN dosage in cancer development and aggressive expressivity. In single copy MYCN (SCN) neuroblastoma cell lines, MYCN has also been demonstrated to enhance proliferation after bFGF administration [18]. Contrariwise, the protein exhibits pro-apoptotic properties in particular conditions such as drug-triggered apoptosis [19,20] or induction of the death receptor machinery by TRAIL [21].
###end p 15
###begin p 16
Thus, MYCN protein exhibits dual properties in proliferation and apoptosis, both in physiological and in pathological conditions.
###end p 16
###begin p 17
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 103 112 103 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro </italic>
###xml 197 201 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 207 209 203 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 201 209 201 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 391 396 387 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 463 467 459 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 473 475 465 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 467 475 463 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 689 693 681 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 699 701 687 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 693 701 685 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
In the present work, we evidenced a link between MYCN transcription and the level of MYCN translation. In vitro translation of the two coding mRNAs led to different levels of MYCN expression, with MYCNDelta1b mRNA being the most efficient. Their translation was differently regulated by an uORF located in the long 5' untranslated region of exon 1a/b. Moreover, we observed that the uORF of MYCN mRNA was able to up-regulate MYCN translation, whereas the uORF of MYCNDelta1b mRNA was not. Our results demonstrated a MYCN dosage effect in SH-EP cells in which high amounts of MYCN were anti-apoptotic after serum deprivation, compared to low levels or absence of MYCN. Finally, the uORF of MYCNDelta1b mRNA directed the translation of a new protein of unknown function, MYCNOT.
###end p 17
###begin title 18
Methods
###end title 18
###begin title 19
Cell culture
###end title 19
###begin p 20
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 385 386 378 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 213 217 <span type="species:ncbi:9913">calf</span>
SH-EP cell line (an epithelial substrate-adherent Schwann-like clone issued from SK-N-SH neuroblastoma cell line[22] that do not express MYCN protein was cultured in RMPI 1640 (Sigma) supplemented with 10% foetal calf serum (GIBCO), penicillin G (200 IU/mL; GIBCO), streptomycin sulphate (200 muG/mL; GIBCO) and L-glutamine (2 mM; GIBCO) at 37degreesC in an atmosphere containing 5% CO2.
###end p 20
###begin title 21
Plasmids preparation
###end title 21
###begin p 22
###xml 57 61 57 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174; </sup>
###xml 391 403 389 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-uORF/MYCN </italic>
###xml 499 504 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 576 587 574 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-uORF/MYCN</italic>
###xml 593 594 587 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 587 594 585 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b</italic></sup>
###xml 688 692 682 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 698 700 688 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 692 700 686 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 770 777 760 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN </italic>
###xml 781 787 771 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN</italic>
###xml 793 794 779 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 787 794 777 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b</italic></sup>
###xml 915 920 901 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 924 928 910 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 934 936 916 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 928 936 914 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 961 969 943 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pDEST40 </italic>
###xml 1000 1004 982 984 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174; </sup>
###xml 100 105 <span type="species:ncbi:9606">human</span>
Plasmid preparations were based on the Invitrogen Gateway(R) technology. Inserts were prepared from human foetal brain mRNAs (Clontech) with a forward primer specific to the very beginning of exon 1a/b at +1865 (according to Genbank ) flanked with an attB1 sequence. Depending on the desired construct, three reverse primers extended with an attB2 sequence were designed. The first one, for p-uORF/MYCN was complimentary to the sequence of the penultimate nucleotides of the first stop codon of the MYCN mRNA in frame with the uAUG codon located at +1894. The second one, for p-uORF/MYCNDelta1b, was complimentary to the sequence of the penultimate nucleotides of the first stop codon of MYCNDelta1b mRNA in frame with the same uAUG codon. The third reverse primer, for p-MYCN and p-MYCNDelta1b, was complementary to the sequence of the penultimate nucleotides of the MYCN stop codon in exon 3. DNAs amplified from MYCN and MYCNDelta1b mRNAs were inserted into pDEST40 according to Invitrogen Gateway(R) protocols with a C-terminal V5 epitope tag for visualizing protein translation.
###end p 22
###begin p 23
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN</italic>
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mut </italic>
###xml 19 23 19 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>mut </italic></sup>
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN</italic>
###xml 39 40 35 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 42 46 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mut </italic>
###xml 33 46 33 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b</italic>, <italic>mut </italic></sup>
###xml 78 85 74 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN </italic>
###xml 89 95 85 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN</italic>
###xml 101 103 93 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 95 103 91 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 185 189 177 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174; </sup>
The plasmids p-MYCNmut and p-MYCNDelta1b, mut were obtained respectively from p-MYCN and p-MYCNDelta1b by mutation of the upstream AUG located in +1894 into an AUC using the Quickchange(R) Site-Directed Mutagenesis kit (Stratagene).
###end p 23
###begin title 24
Cell transfection
###end title 24
###begin p 25
###xml 210 214 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 243 260 242 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pcDNA/GW-40/lacZ </italic>
###xml 282 289 280 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-EGFP </italic>
For translational studies, three independant experiments were conducted in duplicate: SH-EP cells were sowed at a density of 200000 cells in 6-wells plates and transfected the next day with 3.6 mug of purified MYCN-derived plasmids or control pcDNA/GW-40/lacZ (Invitrogen), 0.4 mug p-EGFP (Clontech) and 8 muL Lipofectamine 2000 (Invitrogen). Cells were harvested 24 hours after transfection.
###end p 25
###begin p 26
###xml 370 371 363 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 406 412 398 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN</italic>
###xml 416 420 408 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 426 428 414 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 420 428 412 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 431 447 419 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pcDNA/GW-40/lacZ</italic>
###xml 457 463 444 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pEGFP </italic>
###xml 214 218 <span type="species:ncbi:9913">calf</span>
###xml 603 607 <span type="species:ncbi:9913">calf</span>
For apoptosis experiments, three independent experiments were conducted in quadruplate: SH-EP cells were sowed at a density of 200000 cells in 6-wells plates and cultured in RMPI 1640 supplemented with 0.5% foetal calf serum, penicillin G (200 IU/mL), streptomycin sulphate (200 muG/mL) and L-glutamine (2 mM) for 48 hours at 37degreesC in an atmosphere containing 5% CO2, then transfected with 3.6 mug of p-MYCN, p-MYCNDelta1b or pcDNA/GW-40/lacZ, 0.4 mug pEGFP and 8 muL Lipofectamine 2000. After transfection, cells were cultured for an additional day in the same medium supplemented with 10% foetal calf serum.
###end p 26
###begin title 27
Western blotting
###end title 27
###begin p 28
###xml 46 51 <span type="species:ncbi:9606">human</span>
Proteins (40 mug) from cell lysates or from a human foetal and adult brain (protein Medleytrade mark; BD Biosciences) were separated by SDS-PAGE and transferred to 0.2 mum-nitrocellulose membranes (Biorad). Protein levels were determined using:
###end p 28
###begin p 29
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
- a mouse anti-V5 epitope monoclonal antibody (1:5000, Invitrogen),
###end p 29
###begin p 30
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 15 20 <span type="species:ncbi:9606">human</span>
- a mouse anti-human beta-ACTIN monoclonal antibody (1:200000, Sigma),
###end p 30
###begin p 31
###xml 4 10 <span type="species:ncbi:9986">rabbit</span>
- a rabbit anti-NGAERSPQSPAGRRA [anti-MYCNOT] peptide polyclonal antibody (1:100, Eurogentec), whose specificity was checked by manufacturer
###end p 31
###begin p 32
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 15 20 <span type="species:ncbi:9606">human</span>
- a mouse anti-human MYCN monoclonal antibody, clone B8.4.B (1:1000, BD Pharmingen).
###end p 32
###begin p 33
###xml 39 43 <span type="species:ncbi:9925">goat</span>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
###xml 80 86 <span type="species:ncbi:9986">rabbit</span>
###xml 103 114 <span type="species:ncbi:3704">horseradish</span>
Primary antibodies were detected using goat anti-mouse (1:10000, Sigma) or anti-rabbit (1:3000, Sigma) horseradish peroxidase-conjugated secondary antibodies, and visualized using an enhanced chemiluminescence HRP substrate (Millipore).
###end p 33
###begin title 34
Cell viability assay
###end title 34
###begin p 35
Cell viability was measured with Uptiblue viable cell counting reagent (Uptima) before serum deprivation and one day after transfection: cells were incubated for two hours after addition of 10% Uptiblue, fluorescence was measured with 530 nm excitation wavelength and 590 nm emission wavelength.
###end p 35
###begin p 36
A one-sided student-t test was performed on the serum deprivation-induced apoptosis calculated as the fluorescence difference between the two measures.
###end p 36
###begin title 37
Results
###end title 37
###begin title 38
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 19 21 15 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 13 21 13 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
MYCN and MYCNDelta1b mRNAs are differently translated
###end title 38
###begin p 39
###xml 173 180 173 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN </italic>
###xml 184 190 184 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN</italic>
###xml 196 198 192 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 190 198 190 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 417 432 413 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pcDNA/GW40/lacZ</italic>
###xml 472 478 468 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN</italic>
###xml 536 542 532 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN</italic>
###xml 548 550 540 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 542 550 538 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 556 558 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2a</xref>
###xml 701 708 693 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-EGFP </italic>
###xml 921 926 913 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 930 934 922 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 940 942 928 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 934 942 926 930 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 1026 1029 1014 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1164 1170 1152 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN</italic>
###xml 1170 1174 1158 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mut </italic>
###xml 1170 1174 1158 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>mut </italic></sup>
###xml 1178 1184 1166 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN</italic>
###xml 1190 1191 1174 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 1193 1197 1177 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mut </italic>
###xml 1184 1197 1172 1181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b</italic>, <italic>mut </italic></sup>
###xml 1280 1285 1264 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 1311 1315 1295 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 1321 1323 1301 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 1315 1323 1299 1303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 1341 1343 1321 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2b</xref>
Since alternative splicing of exon 1b affects a potential upstream open reading frame (uORF), we speculated that it could influence the translation of MYCN protein. Vectors p-MYCN and p-MYCNDelta1b were prepared to allow the translation of MYCN respectively from these two mRNAs. In SH-EP neuroblastoma cells, transfection assays followed by Western blot showed no MYCN expression in presence of the control plasmid (pcDNA/GW40/lacZ), weak but detectable translation from p-MYCN, whereas a very high amount of protein was obtained with p-MYCNDelta1b (Fig. 2a). The observed differences are not a simple consequence of experimental variations in either transfection efficacy, because cotransfection of p-EGFP induced no difference in the number of GFP-expressing cells between experiments (data not shown), or RNA transcription or stability, because semi quantitative RT-PCR analysis showed no difference in the levels of MYCN and MYCNDelta1b transcripts brought by plasmids (data not shown). Upstream ORF is usually known for cis-acting inhibitory effect on translation of the major protein. To test this hypothesis, the upstream AUG was mutated to AUC to produce p-MYCNmut and p-MYCNDelta1b, mut vectors. MYCN levels in SH-EP cells clearly diminished when it was translated from MYCN transcripts, but not from MYCNDelta1b transcripts (Fig. 2b).
###end p 39
###begin p 40
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Exon 1b-splicing, uAUG and MYCN translation</bold>
###xml 45 48 45 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a) </bold>
###xml 138 154 137 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pcDNA/GW40/lacZ </italic>
###xml 164 171 163 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN </italic>
###xml 183 189 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN</italic>
###xml 195 197 190 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 189 197 188 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 357 360 349 352 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b) </bold>
###xml 428 435 419 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN </italic>
###xml 445 451 436 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN</italic>
###xml 451 455 442 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mut </italic>
###xml 451 455 442 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>mut </italic></sup>
###xml 465 471 456 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN</italic>
###xml 477 479 464 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 471 479 462 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 491 497 478 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN</italic>
###xml 503 504 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 506 510 489 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mut </italic>
###xml 497 510 484 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b</italic>, <italic>mut </italic></sup>
Exon 1b-splicing, uAUG and MYCN translation. a) Western blot analysis of 40 mug SH-EP neuroblastoma cells transfected with either control pcDNA/GW40/lacZ (lane 1), p-MYCN (lane 2) or p-MYCNDelta1b (lane 3). Results obtained with -upper panel: a monoclonal antibody against MYCN (1:1000) and -lower panel: a monoclonal antibody against beta-Actin (1:10000). b) Western blot analysis of 40 mug SH-EP cells transfected with either p-MYCN (lane 1), p-MYCNmut (lane 2), p-MYCNDelta1b (lane 3) or p-MYCNDelta1b, mut (lane 4). Results obtained with -upper panel: the anti-MYCN antibody (1:1000) and -lower panel: the anti beta-Actin antibody (1:10000).
###end p 40
###begin title 41
High MYCN dosage enhances cell viability
###end title 41
###begin p 42
###xml 145 160 145 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pcDNA/GW40/lacZ</italic>
###xml 162 168 162 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN</italic>
###xml 173 179 173 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN</italic>
###xml 185 187 181 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 179 187 179 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 215 216 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 252 269 248 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pcDNA/GW-40/lacZ </italic>
###xml 313 320 309 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN </italic>
###xml 503 509 499 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-MYCN</italic>
###xml 515 517 507 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 509 517 505 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
To explore the effect of MYCN dosage, SH-EP cells were subjected to apoptosis by 48-hour serum deprivation, then transfected with either control pcDNA/GW40/lacZ, p-MYCN, or p-MYCNDelta1b plasmids. As shown in Table 1, when SH-EP cells did not express (pcDNA/GW-40/lacZ transfected cells) or expressed low amount (p-MYCN transfected cells) of MYCN protein, serum deprivation induced similar cell loss (respectively 35.56% +/- 6.68% and 34.94 +/- 7.19%; p = 0.60). When SH-EP cells expressed high levels (p-MYCNDelta1b transfected cells) of MYCN protein, apoptosis (26.72% +/- 8.09%) was significantly (p = 0.01 and p = 0.02 respectively compared to previous conditions) reduced by one third.
###end p 42
###begin p 43
MYCN dose-dependant anti-apoptotic effect after serum deprivation.
###end p 43
###begin p 44
###xml 131 132 131 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 154 171 154 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> pcDNA/GW-40/lacZ</italic>
###xml 174 176 174 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </sup>
###xml 198 214 198 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pcDNA/GW-40/lacZ</italic>
###xml 216 218 216 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> c</sup>
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pMYCN</italic>
MYCN dose-dependant enhanced SH-EP viability after serum deprivation measured with Uptiblue viable cell counting reagent (Uptima). a p= 0.60 compared with pcDNA/GW-40/lacZ ; b p= 0.01 compared with pcDNA/GW-40/lacZ ; c p= 0.02 compared with pMYCN
###end p 44
###begin title 45
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 54 56 50 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 48 56 48 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
MYCNOT is translated from a upstream AUG of MYCNDelta1b mRNA
###end title 45
###begin p 46
###xml 199 200 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 201 210 201 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uORF/MYCN</italic>
###xml 216 217 212 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 210 217 210 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b</italic></sup>
###xml 246 250 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 255 258 247 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1b </italic>
###xml 250 258 246 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;<italic>1b </italic></sup>
###xml 371 381 363 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-uORF/Myc</italic>
###xml 426 431 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 457 459 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3a</xref>
###xml 506 511 498 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
We speculated that uAUG, located in +1894 (according to GenBank: , may initiate the translation and we assessed the importance of alternative splicing of exon 1b. In SH-EP cells, the transfection of p-uORF/MYCNDelta1b, which contains the uORF of MYCNDelta1b mRNA, allowed the production of a V5 epitope-tagged protein of approximately 15 kDa, whereas the transfection of p-uORF/Myc, which contains the uORF of the full length MYCN transcript, did not (Fig. 3a). This 11.8 kDa new protein was named MYCNOT: MYCN Overlap Transcript.
###end p 46
###begin p 47
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Translation of uORF and existence of MYCNOT</bold>
###xml 45 48 45 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a) </bold>
###xml 89 101 89 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-uORF/MYCN </italic>
###xml 113 124 113 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-uORF/MYCN</italic>
###xml 130 132 126 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 124 132 124 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 366 369 358 361 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b) </bold>
###xml 403 414 395 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-uORF/MYCN</italic>
###xml 420 421 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 414 421 406 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b</italic></sup>
###xml 696 699 683 686 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c) </bold>
###xml 599 605 <span type="species:ncbi:9986">rabbit</span>
Translation of uORF and existence of MYCNOT. a) SH-EP cells were transfected with either p-uORF/MYCN (lane 1) or p-uORF/MYCNDelta1b (lane 2). Western blot was conducted on 40 mug proteins, 48 hours after transfection with -upper panel: a monoclonal antibody against the V5 epitope (1:300) and -lower panel: the anti beta-Actin antibody (1:10000). L: protein ladder; b) SH-EP cells were transfected with p-uORF/MYCNDelta1b. Western blot was conducted on 40 mug protein, 48 hours after transfection with -left panel: a monoclonal antibody against the V5 epitope (1:300) and -right panel: a polyclonal rabbit anti-NGAERSPQSPAGRRA peptide [anti-MYCNOT] polyclonal antibody (1:100) L: protein ladder; c) Western blot analysis of 40 mug protein extracts from adult (lane 1) and foetal (lane 2) brain. Results obtained with -upper panel: the anti-MYCNOT antibody (1:100) and -lower panel: the anti beta-Actin antibody (1:10000).
###end p 47
###begin p 48
###xml 322 323 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 324 333 324 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uORF/MYCN</italic>
###xml 339 341 335 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 333 341 333 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 402 404 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3b</xref>
###xml 508 510 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3c</xref>
###xml 145 151 <span type="species:ncbi:9986">rabbit</span>
To validate the existence of endogenous MYCNOT, we performed a Western blot analysis using a specifically designed polyclonal antibody raised in rabbit against a N-terminal epitope (NGAERSPQSPAGRRA) [anti-MYCNOT] of the hypothetical protein. The designed MYCNOT antibody was able to detect in transfected SH-EP cells with p-uORF/MYCNDelta1b the same protein detected with the V5 epitope antibody (Fig. 3b), The anti-MYCNOT antibody was able to detect a ~12 kDa protein in foetal but not in adult brain (Fig. 3c), thus confirming the existence of an endogenous MYCNOT protein. An analysis of MYCNOT sequence with BLAST and PROSITE software did not show any sequence or motif homology.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 172 174 168 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 166 174 166 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 278 284 274 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al </italic>
###xml 372 373 364 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 418 423 410 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 427 431 419 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 437 439 425 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 431 439 423 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 506 510 494 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 516 518 500 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 510 518 498 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 705 706 689 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 895 900 879 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 941 945 925 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 951 953 931 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 945 953 929 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 1069 1070 1049 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1071 1073 1051 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1239 1243 1219 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 1249 1251 1225 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 1243 1251 1223 1227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 1257 1258 1233 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1259 1261 1235 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1262 1264 1238 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
Because upstream ORF are known to influence protein translation [23], we investigated the MYCN translation from the full length MYCN mRNA and the exon 1b-spliced MYCNDelta1b mRNA. Only these two mRNAs are able to translate the MYCN protein. More recently, in 2005, van Bokhoven et al described a new exon 1a/2-spliced mRNA able to translate a new protein named DeltaMYCN [4]. In SH-EP cells, we demonstrated that both MYCN and MYCNDelta1b were able to translate the MYCN protein, but MYCN translation from MYCNDelta1b mRNA was much more efficient. This difference may not be attributed to a differential stability of the two transcripts because they have the same half-life of approximatively 15 minutes [2]. But, that could be due to differences in the regulating activities of uORFs in the two mRNAs. Because, the coding AUG is several hundreds nucleotides after the stop codon of the uORF in MYCN mRNA compared to the overlapping uORF in MYCNDelta1b transcript, we should have expected a higher translation of MYCN protein from full length mRNA due to reinitiation [6,23], but as already demonstrated, this mRNA contains an Internal Ribosome Entry Site (IRES) that could explain the higher initiation of translation at the major AUG in MYCNDelta1b mRNA [5,24,25].
###end p 50
###begin p 51
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 229 233 229 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 239 241 235 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 233 241 233 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 294 299 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 311 316 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 468 472 464 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 478 480 470 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 472 480 468 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 571 576 563 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 765 767 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 726 731 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 753 758 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Upstream ORFs are usually known for their cis-acting inhibitory activity on the translation of the major protein [7,26-30]. To test this hypothesis, uAUG was mutated into AUC. This mutation had no effect on MYCN translation from MYCNDelta1b mRNA but significantly impacted the translation from MYCN mRNA. Thus, MYCN uORFs have different cis-regulatory activities in MYCN translation depending on the alternative splicing of exon 1b. In our conditions, the uORF of the MYCNDelta1b mRNA did not affect MYCN translation. Alternatively, the uORF transcribed from full length MYCN mRNA has cis-enhancing activity on MYCN translation. To our knowledge, only one team has shown that an uORF is able to augment the translation of the HIV-1 Env protein from the HIV-1 mRNA [30]. Taken together, our results suggest the existence of a new level of MYCN regulation. One hypothesis should be further explored: in cap-dependent conditions, low-level MYCN would be produced from the full length mRNA and this translation would be sustained by the activity of the uORF whereas in IRES-dependent conditions, high-level MYCN would be produced from exon 1b-spliced mRNA, independently of the uORF.
###end p 51
###begin p 52
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
Numerous experiments have demonstrated important ontogenic [31] and oncogenic [14] roles. The amplification and overexpression of MYCN primarily found in 25% of neuroblastomas [16] and in other tumours including medulloblastoma, retinoblastoma, small cell lung cancer, glioblastoma and other embryonal tumours [17] suggest the implication of MYCN dosage in cancer development and aggressive expressivity.
###end p 52
###begin p 53
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 108 110 104 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 102 110 102 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 264 269 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 503 505 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 599 616 595 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pBabe-hygro/MYCN </italic>
###xml 673 675 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 700 706 696 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al </italic>
###xml 822 824 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
Our results showed that, in transfected SH-EP neuroblastoma cells, high MYCN dosage obtained with MYCNDelta1b mRNA translation induces a weak but significant antiapoptotic effect after serum deprivation that was not observed with low MYCN expression obtained with MYCN mRNA. Our results do not fit the accepted pro-apoptotic properties of MYCN: using a MYCN-inducible SH-EP Tet21/N cell line, it has been demonstrated that MYCN overexpression enhances either doxorubicin- or platinum-induced apoptosis [19]. Using a similar approach, Cui et al have shown that the transfection of SH-EP cells with a pBabe-hygro/MYCN vector sensitises the cells to TRAIL-triggered apoptosis[21]. But, as we did, Jasty et al have reported a significant increase of cell viability with high MYCN expression after 6 days of serum deprivation [32]. These different results and ours suggest that MYCN overexpression in SH-EP cells might have different effects depending on the existence of an intrinsic (serum deprivation) or extrinsic (TRAIL or drug-induced apoptosis) pathway-mediated apoptosis. Thus, MYCN dosage, depending on translation of the alternatively exon 1b splicing mRNA, enhances cell viability after intrinsic pathway-mediated apoptosis.
###end p 53
###begin p 54
###xml 136 137 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 259 260 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 343 348 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 438 439 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 440 441 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 442 444 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 498 507 494 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-vitro </italic>
###xml 555 557 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 594 598 590 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC </italic>
###xml 613 618 609 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 756 758 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 972 974 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1100 1102 1096 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1283 1284 1275 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 938 943 <span type="species:ncbi:9606">human</span>
As previously proposed, the uAUG codon located in exon 1a may initiate the translation of DeltaMYCN, a new isoform of the MYCN protein [4]. It has also been hypothesized, but not proven at this time, that this uAUG is able to translate a protein (GenBank: ) [5]. We now demonstrated the existence of this 11.8 kDa protein and named it MYCNOT: MYCN Overlap Transcript. Even if uORFs appear to apply to as much as 50% of the transcriptome [6,7,23], only few papers have reported their translation in in-vitro experiments using chimeric tag-fusion proteins [23]. This is particularly true for the MYC gene, to which MYCN is related, which presents several uORFs: one uORF in exon 1 conducts to the translation of a protein of unknown function called MYCHEX1 [33]. To our knowledge, only one team, using two-dimensional chromatography and mass spectrometry analysis, has been able to prove the existence of eight proteins encoded by uORFs in human K562 and HEK293 cell lines [34]. Moreover, these small proteins (< 20 kDa) were not subject to rapid proteasome degradation suggesting functional activity [34]. The MYCNOT protein, which has no homology with MYCN, other known proteins or protein motifs, shares exon 1a-encoded amino acids with the putative DeltaMYCN previously described [4]. Because MYCNOT is translated in foetal but not adult brain, we may hypothesize that it plays a role during neural development. Our results need further analysis to determine the functions of MYCNOT and might provide new insights into MYCN regulation.
###end p 54
###begin title 55
Conclusion
###end title 55
###begin p 56
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 134 136 130 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 128 136 128 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 242 247 238 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN </italic>
###xml 260 264 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 270 272 262 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 264 272 260 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
###xml 313 317 305 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 323 325 311 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 317 325 309 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
The MYCN gene is transcribed into two major mRNAs which are differently translated. Higher levels of protein were seen with MYCNDelta1b mRNA. Existence of an upstream ORF was shown to have positive cis-regulatory activity on translation from MYCN but not from MYCNDelta1b mRNA. The high MYCN dosage obtained with MYCNDelta1b mRNA translation induces, in transfected SH-EP neuroblastoma cells, a weak but significant antiapoptotic effect after serum deprivation that was not observed with low MYCN expression.
###end p 56
###begin p 57
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYCN</italic>
###xml 102 104 98 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </italic>
###xml 96 104 96 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;1<italic>b </italic></sup>
Here, we show the translation of a new protein of unknown function from the upstream AUG of MYCNDelta1b mRNA.
###end p 57
###begin p 58
In conclusion, further studies are now needed to explore the exact relationship between alternative splicing of exon 1b, MYCN dosage, and the mechanism, either extrinsic or intrinsic, underlying apoptosis.
###end p 58
###begin title 59
Competing interests
###end title 59
###begin p 60
The authors declare that they have no competing interests.
###end p 60
###begin title 61
Authors' contributions
###end title 61
###begin p 62
RB carried out the design of the study and manuscript writing and participated in plasmids preparation, cell culture and Western blotting experiments. SWV participated to design of the study and manuscript writing. CL participated to cell culture and Western blotting experiments. CDB participated to plasmids preparation, cell culture and Western blotting experiments. GT participated to cell culture and Western blotting experiments. ACJ participated to cell culture and Western blotting experiments. EG participated to cell culture and Western blotting experiments. AP participated to design of the study and manuscript writing. All authors read and approved the final manuscript."
###end p 62
###begin title 63
Pre-publication history
###end title 63
###begin p 64
The pre-publication history for this paper can be accessed here:
###end p 64
###begin p 65

###end p 65
###begin title 66
Acknowledgements
###end title 66
###begin p 67
The authors are grateful to Dr. A. Denuziere for statistical assistance and to Mrs M.-D. Reynaud for editorial assistance. This work was supported by INCa Projet Libre 2006-2008 PL 06-76.
###end p 67
###begin article-title 68
###xml 34 39 <span type="species:ncbi:9606">human</span>
Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc
###end article-title 68
###begin article-title 69
Alternative processing of RNA transcribed from NMYC
###end article-title 69
###begin article-title 70
Sequence of a germ-line N-myc gene and amplification as a mechanism of activation
###end article-title 70
###begin article-title 71
MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome
###end article-title 71
###begin article-title 72
N-myc translation is initiated via an internal ribosome entry segment that displays enhanced activity in neuronal cells
###end article-title 72
###begin article-title 73
###xml 63 68 <span type="species:ncbi:9606">human</span>
uORFs, reinitiation and alternative translation start sites in human mRNAs
###end article-title 73
###begin article-title 74
###xml 104 110 <span type="species:ncbi:9606">humans</span>
Upstream open reading frames cause widespread reduction of protein expression and are polymorphic among humans
###end article-title 74
###begin article-title 75
Complex controls: the role of alternative promoters in mammalian genomes
###end article-title 75
###begin article-title 76
###xml 74 79 <span type="species:ncbi:9606">human</span>
Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour
###end article-title 76
###begin article-title 77
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse
###end article-title 77
###begin article-title 78
N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation
###end article-title 78
###begin article-title 79
Nmyc plays an essential role during lung development as a dosage-sensitive regulator of progenitor cell proliferation and differentiation
###end article-title 79
###begin article-title 80
Regulation of the neural crest cell fate by N-myc: promotion of ventral migration and neuronal differentiation
###end article-title 80
###begin article-title 81
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture
###end article-title 81
###begin article-title 82
###xml 52 67 <span type="species:ncbi:10090">transgenic mice</span>
Targeted expression of MYCN causes neuroblastoma in transgenic mice
###end article-title 82
###begin article-title 83
Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas
###end article-title 83
###begin article-title 84
The MYCN oncogene as a specific and selective drug target for peripheral and central nervous system tumors
###end article-title 84
###begin article-title 85
###xml 37 42 <span type="species:ncbi:9606">human</span>
Enhanced MYCN oncogene expression in human neuroblastoma cells is associated with altered FGF receptor expression and cellular growth response to basic FGF
###end article-title 85
###begin article-title 86
MycN sensitizes neuroblastoma cells for drug-triggered apoptosis
###end article-title 86
###begin article-title 87
Targeted MYCN expression affects cytotoxic potential of chemotherapeutic drugs in neuroblastoma cells
###end article-title 87
###begin article-title 88
Linking of N-Myc to death receptor machinery in neuroblastoma cells
###end article-title 88
###begin article-title 89
###xml 60 65 <span type="species:ncbi:9606">human</span>
Coordinate morphological and biochemical interconversion of human neuroblastoma cells
###end article-title 89
###begin article-title 90
###xml 18 23 <span type="species:ncbi:9606">human</span>
uAUG and uORFs in human and rodent 5'untranslated mRNAs
###end article-title 90
###begin article-title 91
Identification of internal ribosome entry segment (IRES)-trans-acting factors for the Myc family of IRESs
###end article-title 91
###begin article-title 92
Canonical initiation factor requirements of the Myc family of internal ribosome entry segments
###end article-title 92
###begin article-title 93
Stress-induced translation of ATF5 mRNA is regulated by the 5'-untranslated region
###end article-title 93
###begin article-title 94
Regulation of endothelial argininosuccinate synthase expression and NO production by an upstream open reading frame
###end article-title 94
###begin article-title 95
The Tie2 5' untranslated region is inhibitory to 5' end-mediated translation initiation
###end article-title 95
###begin article-title 96
###xml 26 31 <span type="species:ncbi:9606">human</span>
TGF-beta(1) regulation of human AT(1) receptor mRNA splice variants harboring exon 2
###end article-title 96
###begin article-title 97
###xml 26 31 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A minimal uORF within the HIV-1 vpu leader allows efficient translation initiation at the downstream env AUG
###end article-title 97
###begin article-title 98
N-Myc functions in transcription and development
###end article-title 98
###begin article-title 99
Bcl-2 and M-Myc coexpression increases IGF-IR and features of malignant growth in neuroblastoma cell lines
###end article-title 99
###begin article-title 100
###xml 19 24 <span type="species:ncbi:9606">human</span>
Translation of the human c-myc P0 tricistronic mRNA involves two independent internal ribosome entry sites
###end article-title 100
###begin article-title 101
###xml 76 81 <span type="species:ncbi:9606">human</span>
Diversity of translation start sites may define increased complexity of the human short ORFeome
###end article-title 101

